These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET. Choi JS, Choi Y, Kim EK, Yoon JH, Youk JH, Han KH, Moon HJ, Kang WJ, Kwak JY. Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573 [Abstract] [Full Text] [Related]
3. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Sager S, Vatankulu B, Sahin OE, Cınaral F, Uslu L, Baran A, Ozturk T, Sönmezoglu K. J Cancer Res Ther; 2018 Feb; 14(5):989-993. PubMed ID: 30197336 [Abstract] [Full Text] [Related]
4. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT). Familiar C, Merino S, Valhondo R, López C, Pérez X, De Los Monteros PE, Hernández F, Pazos M, Pallarés R, Pascual AC. Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900 [Abstract] [Full Text] [Related]
5. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation. Hagenimana N, Dallaire J, Vallée É, Belzile M. J Otolaryngol Head Neck Surg; 2017 Mar 21; 46(1):22. PubMed ID: 28320460 [Abstract] [Full Text] [Related]
6. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation. Prichard RS, Cotter M, Evoy D, Gibbons D, Collins C, McDermott E, Skehan S. Ir Med J; 2011 Jun 21; 104(6):177-9. PubMed ID: 22111394 [Abstract] [Full Text] [Related]
7. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values. Kao YH, Lim SS, Ong SC, Padhy AK. Can Assoc Radiol J; 2012 Nov 21; 63(4):289-93. PubMed ID: 22136969 [Abstract] [Full Text] [Related]
9. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. Bertagna F, Treglia G, Piccardo A, Giubbini R. J Clin Endocrinol Metab; 2012 Nov 21; 97(11):3866-75. PubMed ID: 22904176 [Abstract] [Full Text] [Related]
10. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S. Hematol Oncol; 2011 Jun 21; 29(2):67-74. PubMed ID: 20635328 [Abstract] [Full Text] [Related]
11. Thyroid Incidentalomas Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography: Malignant Risk Stratification and Management Plan. Chung SR, Choi YJ, Suh CH, Kim HJ, Lee JJ, Kim WG, Sung TY, Lee YM, Song DE, Lee JH, Baek JH. Thyroid; 2018 Jun 21; 28(6):762-768. PubMed ID: 29759033 [Abstract] [Full Text] [Related]
12. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Nucl Med Commun; 2009 Mar 21; 30(3):240-4. PubMed ID: 19262287 [Abstract] [Full Text] [Related]
13. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy. Wong C, Lin M, Chicco A, Benson R. Acta Radiol; 2011 Oct 01; 52(8):899-904. PubMed ID: 21873505 [Abstract] [Full Text] [Related]
14. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients. Yoon JH, Cho A, Lee HS, Kim EK, Moon HJ, Kwak JY. Surgery; 2015 Nov 01; 158(5):1314-22. PubMed ID: 25958065 [Abstract] [Full Text] [Related]
17. 18F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation. Pattison DA, Bozin M, Gorelik A, Hofman MS, Hicks RJ, Skandarajah A. J Nucl Med; 2018 May 01; 59(5):749-755. PubMed ID: 29025986 [Abstract] [Full Text] [Related]
18. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM. AJNR Am J Neuroradiol; 2009 Aug 01; 30(7):1431-4. PubMed ID: 19342543 [Abstract] [Full Text] [Related]
19. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Salvatori M, Melis L, Castaldi P, Maussier ML, Rufini V, Perotti G, Rubello D. Biomed Pharmacother; 2007 Sep 01; 61(8):488-93. PubMed ID: 17604940 [Abstract] [Full Text] [Related]
20. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK. Ann Nucl Med; 2010 Dec 01; 24(10):721-8. PubMed ID: 20830537 [Abstract] [Full Text] [Related] Page: [Next] [New Search]